Literature DB >> 23917371

Recurrent confusional episodes associated with hypomagnesaemia due to esomeprazol.

Montserrat G Delgado1, Sergio Calleja, Lorena Suarez, Julio Pascual.   

Abstract

In February 2011, the Food and Drug Administration informed that prescription of proton pump inhibitor (PPI) drugs may cause low serum magnesium levels if taken for prolonged periods of time. We present an ex-smoker, 76-year-old man, with high blood pressure, diabetes mellitus and Barrett's oesophagus (treated with esomeprazole since 2003) admitted due to fluctuating aphasia. Neurovascular and neuroimaging studies were normal. Dyslipidemia and atrial arrhythmia were discovered. The patient was discharged with the diagnosis of left middle cerebral artery transient ischaemic attack and anticoagulation treatment was recommended. The patient returned to the emergency department on further two occasions (confusional episodes) and was admitted in order to complete the neurological study that was normal. The patient was discharged with the diagnosis of probable epileptic seizures. After a week, he was admitted due to generalised temblor and unsteadiness. A complete blood test was performed and showed a severe hypomagnesaemia (not previously performed).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23917371      PMCID: PMC3762399          DOI: 10.1136/bcr-2013-200501

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Magnesium metabolism and its disorders.

Authors:  R Swaminathan
Journal:  Clin Biochem Rev       Date:  2003-05

Review 2.  Hypomagnesemia: an evidence-based approach to clinical cases.

Authors:  Farahnak Assadi
Journal:  Iran J Kidney Dis       Date:  2010-01       Impact factor: 0.892

3.  Focal cerebral deficits in severe hypomagnesemia.

Authors:  C R Leicher; A G Mezoff; J S Hyams
Journal:  Pediatr Neurol       Date:  1991 Sep-Oct       Impact factor: 3.372

4.  [Effects of hypomagnesemia].

Authors:  A Forest; A Lemaire; J Boddaert; M Verny
Journal:  Rev Med Interne       Date:  2009-04-16       Impact factor: 0.728

Review 5.  Magnesium: clinical considerations.

Authors:  E L Tso; R A Barish
Journal:  J Emerg Med       Date:  1992 Nov-Dec       Impact factor: 1.484

Review 6.  The role of magnesium in hypertension and cardiovascular disease.

Authors:  Mark Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-09-26       Impact factor: 3.738

  6 in total
  4 in total

1.  Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention.

Authors:  Sang-Ho Park; Sun-Hyo Lee; Ji-Sung Lee; Won-Yong Shin; Hyo-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong
Journal:  Kidney Res Clin Pract       Date:  2015-03-27

2.  Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.

Authors:  Krishnan Swaminathan
Journal:  Indian J Pharmacol       Date:  2015 May-Jun       Impact factor: 1.200

Review 3.  Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences.

Authors:  Gloria Ortiz-Guerrero; Diana Amador-Muñoz; Carlos Alberto Calderón-Ospina; Daniel López-Fuentes; Mauricio Orlando Nava Mesa
Journal:  Neural Plast       Date:  2018-03-21       Impact factor: 3.599

4.  The Janus-like Association between Proton Pump Inhibitors and Dementia.

Authors:  Anna Papazoglou; Muhammad I Arshaad; Christina Henseler; Johanna Daubner; Karl Broich; Britta Haenisch; Marco Weiergräber
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.